Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

Publisher: John Wiley & Sons Inc

E-ISSN: 1582-4934|22|2|1070-1080

ISSN: 1582-1838

Source: Journal of Cellular and Molecular Medicine, Vol.22, Iss.2, 2018-02, pp. : 1070-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract